UCSD team adapts CRISPR to edit RNA for disease therapies – The San Diego Union-Tribune
The San Diego Union-Tribune |
UCSD team adapts CRISPR to edit RNA for disease therapies
The San Diego Union-Tribune Scientists led by UC San Diego’s Gene Yeo modified CRISPR so it doesn’t target DNA and instead attacks specific RNA sequences, while leaving others alone. This specificity is vital for therapeutic purposes. It is delivered by an adenovirus, a virus … RNA-targeting CRISPR could yield treatments for Huntington’s, ALSFierceBiotech CRISPR Corrects RNA-based Disease DefectsThe Scientist Researchers Use CRISPR to Destroy Pathogenic RNA Species Linked to Huntington’s Disease, ALSGenomeWeb Phys.Org –KPBS all 6 news articles » |
Immuno-Oncology News |
Dozens of New Genes with Resistance to Cancer Immunotherapy Discovered
Immuno-Oncology News “We cast a wide, deep net and conducted an unbiased survey of all of the 19,000 genes in the cancer’s genome – not just the genes that are known to be involved in creating immunotherapy-resistant tumors,” Nicholas P. Restifo, MD, said in a press release. |
Immuno-Oncology News |
Dozens of New Genes with Resistance to Cancer Immunotherapy Discovered
Immuno-Oncology News “We cast a wide, deep net and conducted an unbiased survey of all of the 19,000 genes in the cancer’s genome – not just the genes that are known to be involved in creating immunotherapy-resistant tumors,” Nicholas P. Restifo, MD, said in a press release. |
TIME |
Cancer’s Newest Miracle Cure
TIME What makes immune-based therapies like CAR T cell therapy so promising–and so powerful–is that they are a living drug churned out by the patients themselves. The treatment isn’t a pill or a liquid that has to be taken regularly, but a one-hit wonder … |
|
ICER Seeks Public Comment on Scoping Document for CAR–T Treatments
AJMC.com Managed Markets Network CAR–T cells are being considered the next frontier of cell-based immunotherapy to move from the bench to the bedside. By modifying a patient’s own T cells, CAR-T treatments transduce the patient’s T cells to express a cell surface receptor that can … |